Transparency Market Research

At 0.3% CAGR, Global Antibacterial Drugs Market to Stagnate Due to Emergence of Drug-Resistant Bacterial Strains

Antibacterial Drugs Market (By Class - Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides and Phenicols, and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019


Albany, NY -- (SBWIRE) -- 06/23/2015 -- A new research report from U.S.-based Transparency Market Research examines the global antibacterial drugs market and arrives at studied conclusions about the market's expected trajectory during the forecast period 2013-2019. The report states that the global market for antibacterial drugs was worth US$43.55 billion in 2012. Helped by factors such as the growing prevalence of bacterial diseases around the world and growth in geriatric population with weakened immune systems due to age, the market is expected to rise at a 0.3% CAGR from 2013 to 2019, to eventually reach a total value of US$45.09 billion.The report, titled 'Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019', draws on extensive primary and secondary research to formulate conclusions, employing trusted analytical tools such as Porter's five forces analysis, market attractiveness analysis, and SWOT analysis.

Browse the full Antibacterial Drugs Market Report at

Porter's five forces analysis reveals the tussle between the established players and new entrants, threat to branded products from substitutes, and the relative power of buyers and suppliers. Use of market attractiveness analysis helps develop the crucial part of the report: recommendations for market players regarding the feasibility of investment in the market in the forecast period. SWOT analysis helps expand upon the competitive landscape of the market, to provide a comparative overview of the major players operating in the global antibacterial drugs market."Despite the strong factors working in its favor, the global antibacterial drugs market is restrained by a number of equally influential issues. This is the reason why the CAGR of the market is expected to remain negligible in the forecast period," states a TMR analyst.

Browse the full Press Release :

Major restraints acting on the antibacterial drugs market are the proliferation of generic drugs, aided by ongoing patent expiration of several blockbuster drugs, and rise in multi-drug resistant strains of pathogenic bacteria. The latter is exacerbated by the weak pipeline of novel antibacterial drugs at present, and can be resolved by increased funding on constantly evolving product development.The antibacterial drugs market is segmented into seven segments by drug class, of which B-Lactams emerged as the market leader in 2012, holding a whopping 57% share in the market. Quinolones, which were the second largest class of antibacterial drugs in the global market the same year, are expected to regress in the forecast period owing to heightened risk of complications due to the usage of this quinolones and impending patent expirations.Of pipeline antibacterial drugs, the report profiles the data regarding delafloxacin, surotomycin, ceftolozane/tazobactam, tedizolid, dalbavancin, CAZ AVI, oritavancin, and others. Forecasts for the development of these products till 2019 are presented in the report.

Among the major antibacterial drugs market players, the report examines the business operations, product catalog, and financial standing of companies such as Bayer AG, AstraZeneca, Eli Lilly, Johnson and Johnson, Merck, Sanofi, GSK, Sanofi, Pfizer, and Novartis. A comprehensive overview of the market's competitive landscape is presented in the report to aid market stakeholders assess market conditions and modify their market strategies accordingly.

Request a Brochure of this Report:

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free: 866-552-3453